氯吡格雷对脑梗死患者超敏C反应蛋白的影响  

Effect of Clopidogrel on High Sensitivity C-reactive Protein in Patients with Acute Cerebral Infarction

作　　者：余琳玲[1] 蔡学礼[1] 李珊[1] 

机构地区：[1]丽水市中心医院神经内科,浙江丽水323000

出　　处：《药物流行病学杂志》2010年第1期15-16,共2页Chinese Journal of Pharmacoepidemiology

摘　　要：目的:探讨氯吡格雷对急性脑梗死患者神经功能及血清高敏感C反应蛋白(hs-CRP)水平的影响。方法:选择急性脑梗死患者100例,随机分为氯吡格雷治疗组、对照组各50例,两组患者均在治疗前及治疗后14d时采用乳胶增强免疫比浊法检测hs-CRP,并行神经功能缺损记分(NIHSS)量表测定。结果:治疗后14d氯吡格雷治疗组神经功能缺损评分与对照组比较有统计学意义(P<0.01);治疗后14d治疗组hs-CRP水平明显低于对照组,有统计学意义(P<0.05)。结论:氯吡格雷能改善急性脑梗死患者的神经功能,对急性脑梗死后继发炎症反应有抑制作用。Objective： To investigate the effect of clopidogrel on high sensitivity C-reactive protein and neurological function in patients with acute cerebral infarction. Method： 100 patients with cerebral infarction were randomly divided into two groups. In the treatment group the patients were given 75mg clopidogrel everyday. The conventional treatment for the two groups was the same except for clopidogrel. The treatment course in the two groups lasted 14 days. The neurologic impairment scores（ NIHSS） and concentrations of hs-CRP were noted down before the treatment and on the 14th day after the treatment. The 1 evel s of serum hs-CRP were measured by particle enhanced immunoturbidimetry. Result： The decline of the neurologic impairment scores on the 14d after the treatment was more striking in the patients of the treatment group than that of the controlled group （ P 〈 0.01 ）. The decline in the serum level of hs-CRP on the 14d after the treatment was more striking in the patients of the the treatment group than that in the controlled group （P 〈 0. 05）. Conclusion： Clopidogrel can mediate the cerebral ischemia and decrease the inflammatory reaction after cerebral farction .

关 键 词：脑梗死 氯吡格雷 超敏C反应蛋白 

分 类 号：R973.2[医药卫生—药品]